SPEC Share Price Performance
SEK 0.19
-1.84 (-90.74%)
Price SEK 0.19
Share PriceSEK 0.19
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans
Jul 31
SpectraCure AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
SPEC Community Narratives
There are no narratives available yet.
SpectraCure AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.25
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
SpectraCure AB (publ) Competitors
Snowflake Analysis
About SPEC
- Founded
- 2003
- Employees
- 13
- CEO
- WebsiteView website
SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Swedish Market Performance
- 7 Days: 1.7%
- 3 Months: 2.4%
- 1 Year: -0.5%
- Year to Date: 2.9%
The market has climbed 1.7% in the last 7 days, lead by the Industrials sector with a gain of 2.6%. As for last year, the market performance has been flat. Looking forward, earnings are forecast to grow by 16% annually. Market details ›